If they're working with the Alberta IP, it's a use patent for ampakines in RD, but the devil is in the details: does the use patent cover more recently developed ampakines? I've always liked this indication, so I'm happy.
How deep are the pockets of these people? Are they recapitalizing corx,or are they just pitching to potential partners? Do they have the kind of credibility that might open doors?